Evidence map›Paper›PMID 30464529›Full record

ArticleOncoTargets and therapy2018

Intestinal metastasis from primary

Hua-Fei Chen, Qu-Xia Zhang, You-Cai Zhu, Kai-Qi Du, Xiao-Feng Li, Li-Xin Wu, Wen-Xian Wang, Chun-Wei Xu

Open access · goldAbstract readCase Reports
In one paragraph

Article in OncoTargets and therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hua-Fei ChenDepartment of Thoracic Disease Center, Zhejiang Rongjun Hospital, Jiaxing, Zhejiang, China.
Qu-Xia ZhangDepartment of Pathology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, Fujian, China, xuchunweibbb@163.com.
You-Cai ZhuDepartment of Thoracic Disease Center, Zhejiang Rongjun Hospital, Jiaxing, Zhejiang, China.
Kai-Qi DuDepartment of Thoracic Disease Center, Zhejiang Rongjun Hospital, Jiaxing, Zhejiang, China.
Xiao-Feng LiDepartment of Thoracic Disease Center, Zhejiang Rongjun Hospital, Jiaxing, Zhejiang, China.
Li-Xin WuDepartment of Thoracic Disease Center, Zhejiang Rongjun Hospital, Jiaxing, Zhejiang, China.
Wen-Xian WangDepartment of Chemotherapy, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China, helen-0407@163.com.
Chun-Wei XuDepartment of Pathology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, Fujian, China, xuchunweibbb@163.com.
Fujian Medical University · CNZhejiang Cancer Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small intestinal metastases from primary lung cancer are rare. Such patients have a poor prognosis. Early diagnosis of small intestinal metastases is difficult because of the low incidence of clinically apparent symptoms. The standard treatment for small intestinal metastases has not been established. A 69-year-old Chinese man presented for evaluation of a tumor in the right lower lung and mediastinal lymph node enlargement on clinical examination. The clinical stage was cT

Indexed as

crizotiniblung adenocarcinomametastasisROS1small intestine

Identifiers

PMID30464529
PMCPMC6225853
OpenAlexW2899502111

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.